Other
Revenue
Gilead Sciences Revenue decreased by 12.2% to $6.96B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.4%, from $6.67B to $6.96B. Over 4 years (FY 2021 to FY 2025), Revenue shows relatively stable performance with a 1.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOther
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 7, 2026
How to read this metric
An increase indicates growth in market share or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Represents the total consideration received from customers for the sale of goods or services, excluding any sales-relate...
Peer comparison
Standard across all public companies; comparable to 'Net Sales' or 'Total Revenue' at peer distributors.
Metric ID:
other_revenue_from_contract_with_customer_excluding_asse_0d5b70Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.22B | $7.42B | $7.24B | $6.59B | $6.26B | $7.04B | $7.39B | $6.35B | $6.60B | $7.05B | $7.11B | $6.69B | $6.95B | $7.55B | $7.57B | $6.67B | $7.08B | $7.77B | $7.93B | $6.96B |
| QoQ Change | — | +19.4% | -2.4% | -9.0% | -5.0% | +12.5% | +4.9% | -14.0% | +3.9% | +6.8% | +0.9% | -6.0% | +4.0% | +8.5% | +0.3% | -11.9% | +6.2% | +9.7% | +2.0% | -12.2% |
| YoY Change | — | — | — | — | +0.7% | -5.1% | +2.0% | -3.6% | +5.4% | +0.1% | -3.7% | +5.3% | +5.4% | +7.0% | +6.4% | -0.3% | +1.8% | +3.0% | +4.7% | +4.4% |
Range$6.22B – $7.93B
CAGR+2.4%
Avg YoY Growth+2.1%
Median YoY Growth+2.5%
Revenue at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's revenue?
- Gilead Sciences (GILD) reported revenue of $6.96B in Q1 2026.
- How has Gilead Sciences's revenue changed year-over-year?
- Gilead Sciences's revenue increased by 4.4% year-over-year, from $6.67B to $6.96B.
- What is the long-term trend for Gilead Sciences's revenue?
- Over 4 years (2021 to 2025), Gilead Sciences's revenue has grown at a 1.9% compound annual growth rate (CAGR), from $27.31B to $29.44B.
- What does revenue mean?
- The total amount of money earned from selling products or services to customers before taxes.